表紙
市場調查報告書
商品編碼
1040603

低分子預填充式注射器市場:醫藥品分類,各材料類型,各銷售管道,各地區:市場規模,佔有率,展望,機會分析(2021年∼2028年)

Small Molecule Prefilled Syringes Market, by Drug Class, by Material Type, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

出版日期: | 出版商: Coherent Market Insights | 英文 161 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球低分子預填充式注射器的市場規模由於市場參與者專注於產品的銷售和核准,推出和製造功能,在預期期間中將加速增長。

預裝注射器包含正確的劑量,以消除劑量錯誤。許多製藥商將藥瓶裝滿最多 25%,以便為最終用戶提供正確的劑量。然而,對於預充式注射器,由於過度充填而導致的錯誤很少。引進昂貴的生物製藥,有浪費少的優勢,尤其是在疫苗供應短缺或非常昂貴的情況下。

本報告提供全球低分子預填充式注射器市場調查,提供市場概要,市場促進因素與阻礙因素,醫藥品分類·各材料類型·各銷售管道·各地區的市場分析,競爭情形,企業簡介等資訊。

目錄

第1章 調查目的·前提條件

第2章 市場概要

  • 報告概要
    • 市場定義和範圍
  • 摘要整理
    • 市場明細:各醫藥品分類
    • 市場明細:各材料類型
    • 市場明細:各銷售管道
    • 市場明細:各地區
  • 連貫機遇地圖(COM)

第3章 市場動態,法規,趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 波特五力分析
  • 產業趨勢
  • 主要的焦點
  • 流行病學
  • 償付方案
  • 法規方案
  • 產品的銷售與核准
  • 收購與合作方案

第4章 COVID-19的影響分析

  • COVID-19流行病學
  • COVID-19對低分子預填充式注射器的需求與供給的影響
  • COVID-19對醫療部門全體的影響

第5章 全球低分子預填充式注射器市場:各醫藥品分類(2017年-2028年)

  • 概要
  • 心血管藥
  • 神經內科藥
  • 止痛藥
  • 佐劑
  • 其他

第6章 全球低分子預填充式注射器市場:各材料類型(2017年-2028年)

  • 概要
  • 玻璃
  • 塑膠&聚合物

第7章 全球低分子預填充式注射器市場:各銷售管道(2017年-2028年)

  • 概要
  • 醫院藥局
  • 零售藥局
  • 線上藥局

第8章 全球低分子預填充式注射器市場:各地區(2017年-2028年)

  • 概要
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第9章 競爭情形

  • 企業簡介
    • Sanofi*
    • Viatris Inc. (Mylan NV)
    • AstraZeneca Plc
    • F. Hoffmann-La Roche AG (Genentech, Inc.)
    • Sun Pharmaceutical Industries Ltd.
    • Pfizer Inc.
    • Dr. Reddy's Laboratories Ltd.
    • Teva Pharmaceutical Industries Ltd.
    • Fresenius Kabi AG
    • McKesson Corporation.

所提供的重要指南也適用於研究範圍內的其他公司。

  • 分析師的見解

第10章 章節

目錄
Product Code: CMI1629

Prefilled syringes have several advantages over traditional vial packaging, including ease of use. Prefilled syringes obviate the need for the processes that are required before using a drug in a vial. It also helps to eliminate dosing errors because prefilled syringes contain the exact dose. Many pharmaceutical manufacturers overfill vials by up to 25% to ensure that the end user receives the correct dose. However, overfilling can result in errors that are virtually eliminated with prefilled syringes. With the introduction of more expensive biotech drugs, this is advantageous because it means less waste, particularly if some vaccines are in short supply or extremely expensive.

Market Dynamics

Market players are focused on product launches or approvals, which is expected to contribute to the growth of the global small molecule prefilled syringes market over the forecast period. For instance, in March 2018, Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) approved Lucentis (ranibizumab injection) 0.3 mg prefilled syringe (PFS) as a new method of administering the medicine to treat all forms of diabetic retinopathy.

Market players are focused on launching manufacturing capabilities for prefilled syringes. This is expected to drive the market growth over the forecast period. For instance, in July 2019, Terumo Corporation, based in Japan, announced the construction of an additional production facility for pre-filled syringes at its subsidiary Terumo Yamaguchi D&D.

Market players focused on product launches is expected to propel the growth of the global small molecule prefilled syringes market. For instance, in March 2020, Dr. Reddy's Laboratories Ltd., a leading multinational pharmaceutical company, announced the launch of Naloxone Hydrochloride Injection USP, 2 mg/2 mL (1 mg/mL) Single-dose Prefilled Syringe, a therapeutic equivalent generic version of Narcan (naloxone hydrochloride) Injection USP in India.

Key features of the study:

  • This report provides an in-depth analysis of global small molecule prefilled syringes market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global small molecule prefilled syringes market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Sanofi, Viatris Inc. (Mylan N.V.), AstraZeneca Plc, F. Hoffmann-La Roche AG (Genentech, Inc.), Sun Pharmaceutical Industries Ltd., Pfizer Inc., Dr. Reddy's Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, and McKesson Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global small molecule prefilled syringes market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global small molecule prefilled syringes market

Detailed Segmentation:

  • Global Small Molecule Prefilled Syringes Market, By Drug Class:
  • Cardiovascular Drugs
  • Neurology Drugs
  • Analgesics
  • Adjuvants
  • Others
  • Global Small Molecule Prefilled Syringes Market, By Material Type :
  • Glass
  • Plastic & Polymer
  • Cardiovascular Ultrasound Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Small Molecule Prefilled Syringes Market, By Region:
  • North America
  • By Drug Class:
  • Cardiovascular Drugs
  • Neurology Drugs
  • Analgesics
  • Adjuvants
  • Others
  • By Material Type:
  • Glass
  • Plastic & Polymer
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • U.S.
  • Canada
  • Latin America
  • By Drug Class:
  • Cardiovascular Drugs
  • Neurology Drugs
  • Analgesics
  • Adjuvants
  • Others
  • By Material Type:
  • Glass
  • Plastic & Polymer
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Drug Class:
  • Cardiovascular Drugs
  • Neurology Drugs
  • Analgesics
  • Adjuvants
  • Others
  • By Material Type:
  • Glass
  • Plastic & Polymer
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Drug Class:
  • Cardiovascular Drugs
  • Neurology Drugs
  • Analgesics
  • Adjuvants
  • Others
  • By Material Type:
  • Glass
  • Plastic & Polymer
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Drug Class:
  • Cardiovascular Drugs
  • Neurology Drugs
  • Analgesics
  • Adjuvants
  • Others
  • By Material Type:
  • Glass
  • Plastic & Polymer
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Drug Class:
  • Cardiovascular Drugs
  • Neurology Drugs
  • Analgesics
  • Adjuvants
  • Others
  • By Material Type:
  • Glass
  • Plastic & Polymer
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
    • Sanofi *
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Viatris Inc. (Mylan N.V.)
    • AstraZeneca Plc
    • F. Hoffmann-La Roche AG (Genentech, Inc.)
    • Sun Pharmaceutical Industries Ltd.
    • Pfizer Inc.
    • Dr. Reddy's Laboratories Ltd.
    • Teva Pharmaceutical Industries Ltd.
    • Fresenius Kabi AG
    • McKesson Corporation.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Drug Class
    • Market Snippet, By Material Type
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Porter's Analysis
  • Industry Trends
  • Key Highlights
  • Epidemiology
  • Reimbursement Scenario
  • Regulatory Scenario
  • Product Launch and Approvals
  • Acquisition and Collaboration Scenario

4. COVID - 19 Impact Analysis

  • COVID-19 Epidemiology
  • Impact of COVID-19 on Demand and Supply of Small molecule prefilled syringes
  • Impact of COVID-19 on the overall Healthcare Sector

5. Global Small Molecule Prefilled Syringes Market, By Drug Class, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Cardiovascular Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Neurology Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Analgesics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Adjuvants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

6. Global Small Molecule Prefilled Syringes Market, By Material Type, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Glass
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Plastic & Polymer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

7. Global Small Molecule Prefilled Syringes Market, By Distribution Channel, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017- 2028
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

8. Global Small Molecule Prefilled Syringes Market, By Region, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017 - 2028
    • Regional Trends
  • North America
    • Market Size and Forecast, By Drug Class,2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Material Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Drug Class,2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Material Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Drug Class,2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Material Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Drug Class,2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Material Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Drug Class,2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Material Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Drug Class,2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Material Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country/Region, 2017 - 2028 (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

9. Competitive Landscape

  • Company Profiles
    • Sanofi *
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Viatris Inc. (Mylan N.V.)
    • AstraZeneca Plc
    • F. Hoffmann-La Roche AG (Genentech, Inc.)
    • Sun Pharmaceutical Industries Ltd.
    • Pfizer Inc.
    • Dr. Reddy's Laboratories Ltd.
    • Teva Pharmaceutical Industries Ltd.
    • Fresenius Kabi AG
    • McKesson Corporation.

Key pointers provided are also applicable to other companies covered in the scope of the report.

  • Analyst Views

10. Section

  • Research Methodology
  • About us
  • Contact